ProQuad

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2006-2017
0120062017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
BACKGROUND Monovalent varicella vaccines have been available in the Veneto Region of Italy since 2004. In 2006, a single vaccine… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
2017
2017
Macartney et al1 report in this issue of JAMAPediatricson the safety of using combination measles-mumps-rubellavaricella (MMRV… (More)
Is this relevant?
2015
2015
In the EU, the live attenuated, tetravalent measles-mumps-rubella-varicella vaccine ProQuad is indicated for simultaneous… (More)
  • table 3
Is this relevant?
2014
2014
BACKGROUND In randomized clinical studies, over 11,800 children, 12 months to 6 years of age, were administered ProQuad(®), a… (More)
  • table 1
  • figure 1
  • table 3
  • table 4
Is this relevant?
2012
2012
Vaccination against measles, mumps, rubella and varicella (MMRV) is currently recommended in developed countries for infants from… (More)
  • table 1
  • figure 1
  • table 4
  • figure 2
  • figure 3
Is this relevant?
2009
2009
Measles, mumps, and rubella are three common viral childhood diseases that can have serious complications. Active immunization… (More)
Is this relevant?
2006
2006
BACKGROUND A combination measles, mumps, rubella, and varicella vaccine (ProQuad, Merck & Co., Inc, West Point, PA) was evaluated… (More)
Is this relevant?